Galapagos completes private placement by issuance of 2,696,831 new ordinary shares
(Thomson Reuters ONE) -
Mechelen, Belgium; 29 April 2013 - Galapagos NV (Euronext: GLPG) announces that
it has completed its capital increase by issuing today 2,696,831 new ordinary
shares. These shares will be delivered to Belgian and international
institutional and other eligible investors who participated in the ?53.9 million
private placement closed on Wednesday 24 April 2013. The newly issued shares
were admitted to listing on NYSE Euronext Brussels and NYSE Euronext Amsterdam
on 29 April 2013.
Galapagos has a total of 29,665,159 outstanding ordinary shares.
About Galapagos
Galapagos (Euronext: GLPG; OTC: GLPYY) is specialized in novel modes-of-action,
with a large pipeline of four clinical, seven pre-clinical, and 30 discovery
small-molecule and antibody programs in cystic fibrosis, inflammation,
antibiotics, metabolic disease, and other indications.
GLPG0634 is an orally-available, selective inhibitor of JAK1 for the treatment
of rheumatoid arthritis and potentially other inflammatory diseases, about to
enter Phase 2b studies. AbbVie and Galapagos signed a worldwide license
agreement whereby AbbVie will be responsible for further development and
commercialization after Phase 2b. Galapagos has another selective JAK1
inhibitor in Phase 2 in lupus and psoriasis, GSK2586184 (formerly GLPG0778, in-
licensed by GlaxoSmithKline in 2012). GLPG0187 is a novel integrin receptor
antagonist currently in a Phase 1b patient study in metastasis. GLPG0974 is the
first inhibitor of FFA2 to be evaluated clinically for the treatment of IBD;
this program is currently in a Proof of Concept Phase 2 study, with results
expected early 2014.
The Galapagos Group, including fee-for-service companies BioFocus, Argenta and
Fidelta, has around 800 employees and operates facilities in five countries,
with global headquarters in Mechelen, Belgium. Further information at:
www.glpg.com
CONTACT
Galapagos NV
Elizabeth Goodwin, Director Investor Relations
Tel: +31 6 2291 6240
ir(at)glpg.com
IMPORTANT INFORMATION
This release may contain forward-looking statements, including, without
limitation, statements containing the words "believes," "anticipates,"
"expects," "intends," "plans," "seeks," "estimates," "may," "will," "could,"
"stands to," and "continues," as well as similar expressions. Such forward-
looking statements may involve known and unknown risks, uncertainties and other
factors which might cause the actual results, financial condition, performance
or achievements of Galapagos, or industry results, to be materially different
from any historic or future results, financial conditions, performance or
achievements expressed or implied by such forward-looking statements. Given
these uncertainties, the reader is advised not to place any undue reliance on
such forward-looking statements. These forward-looking statements speak only as
of the date of publication of this document. Galapagos expressly disclaims any
obligation to update any such forward-looking statements in this document to
reflect any change in its expectations with regard thereto or any change in
events, conditions or circumstances on which any such statement is based, unless
required by law or regulation.
The distribution of this press release in certain jurisdictions may be
restricted by law. No action has been taken by Galapagos, Jefferies
International Limited, Kempen & Co N.V. or any of their respective affiliates
that would permit a public offer of the new shares in any jurisdiction where
action for that purpose is required. This press release is for information
purposes only and does not constitute an offer to purchase or the solicitation
of an offer to buy any new shares in any jurisdiction in which such an offer or
solicitation is unlawful. Persons into whose possession this press release comes
are required to inform themselves about and to observe any such restrictions.
This press release is not for publication or distribution, directly or
indirectly, in the United States (including its territories and possessions, any
state of the United States and the District of Columbia), Canada, Australia and
Japan. This press release does not constitute or form part of any offer or
solicitation to purchase or subscribe for securities in the United States, nor
does it constitute an offer to sell, or the solicitation of an offer to buy, and
there shall not be any sale of securities, in any jurisdiction in which such
offer, solicitation or sale would be unlawful prior to its registration or
qualification under the laws of such jurisdiction. The new shares mentioned
herein have not been, and will not be, registered under the United States
Securities Act of 1933 (the "Securities Act"). The new shares may not be offered
or sold in the United States except pursuant to an effective registration
statement under, or an exemption from the registration requirements of, the
Securities Act. There will be no public offer of securities in the United
States.
This press release is not an offer to sell nor a solicitation to buy the new
shares nor a prospectus for the purposes of Directive 2003/71/EC (such
Directive, together with any applicable implementing measures in the relevant
member state of the European Economic Area and as amended, including by
Directive 2010/73/EU, to the extent implemented in the relevant member state,
the "Prospectus Directive"). There will be no offer to the public of the new
shares in any member state of the European Economic Area and no prospectus or
other offering document has been or will be prepared in connection with the sale
of the new shares by the Company. In the European Economic Area the new shares
will only be offered and sold to "qualified investors" as defined in the
Prospectus Directive or in other circumstances falling within Article 3(2) of
the Prospectus Directive.
This press release does not constitute an offer of the new shares to the public
in the United Kingdom, nor is it intended to be an inducement to engage in
investment activity for the purpose of section 21 of the Financial Services and
Markets Act 2000 (as amended) of the United Kingdom. Consequently, this press
release is only directed at (i) persons who are outside the United Kingdom; (ii)
investment professionals within Article 19(5) of the Financial Services and
Markets Act 2000 (Financial Promotions) Order 2005 as amended (the "Order");
(iii) persons falling within Article 49(2)(a)-(d) of the Order; or (iv) other
persons to whom it may be lawfully be communicated, together being referred to
as "relevant persons". The new shares are only available to, and any invitation,
offer or agreement to purchase or otherwise acquire the new shares will be
engaged in only with relevant persons. Any person who is not a relevant person
should not act or rely on this document or any of its contents.
This press release does not constitute or form part of, and should not be
construed as an offer or the solicitation of an offer to subscribe for or
purchase the new shares, and nothing contained therein shall form the basis of
or be relied on in connection with any contract or commitment whatsoever, nor
does it constitute a recommendation regarding the new shares. An investment
decision to buy any of the new shares in the private placement must be made
solely on the basis of publicly available information. Such information is not
the responsibility of, and has not been independently verified by any of,
Jefferies International Limited, Kempen & Co N.V., or their respective
affiliates.
Jefferies International Limited, Kempen & Co N.V. are acting only for the
Company in connection with the private placement and no one else, and will not
be responsible to anyone other than the Company for providing the protections
offered to clients of Jefferies International Limited, Kempen & Co N.V. nor for
providing advice in relation to the private placement.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Galapagos NV via Thomson Reuters ONE
[HUG#1697466]
Unternehmensinformation / Kurzprofil:
Datum: 29.04.2013 - 18:01 Uhr
Sprache: Deutsch
News-ID 253996
Anzahl Zeichen: 9621
contact information:
Town:
Mechelen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 189 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Galapagos completes private placement by issuance of 2,696,831 new ordinary shares"
steht unter der journalistisch-redaktionellen Verantwortung von
Galapagos NV (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
